Myriad Genetics rises on 3Q and stronger outlook - Businessweek Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Thursday, May 09, 2013

Myriad Genetics rises on 3Q and stronger outlook - Businessweek



Myriad Genetics rises on 3Q and stronger outlook - Businessweek

".....In mid-April the Supreme Court heard a case related to the patenting of human genes: the case challenges two patents Myriad holds on genes related to the BRACAnalysis test. The American Civil Liberties Union and other groups have argued that the government shouldn't award patents on genes. The Patent & Trademark office has been awarding such patents for decades.
A ruling is expected by June. Analysts expect Myriad's patents to be upheld and note that even if the Supreme Court invalidates the patents, the company has other patents supporting the test."

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.